Loading...

Loading...

Adjust height of sidebar

KMap

People

Adjust height of sidebar

KMap

Profile

Picture of Lizeth Evangelista

Lizeth Evangelista

Regulatory Coordinator II

Cancer Center Division

Collaboration(4)

Linda Garland
Brianna Denton
Ruth Ca?amar
Octavio Castanos

Grants(14)

A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XB002 As Single-Agent And Combination Therapy In Subjects With Inoperable Locally Advanced or Metastatic Solid Tumors
Active·2024·$0 / $1.6M·
External
cancer, pharmacokinetics, drug therapy, clinical trial, tumor treatment
A Phase 1b/2 Open-Label Study of Disitamab Vedotin Monotherapy or in Combination with Other Anti-Cancer Therapies in Solid Tumors
Active·2024·$0 / $724K·
External
cancer, immunotherapy, clinical trial, monotherapy, combination therapy
A Phase 1 Study With ABBV-CLS-484 Alone And In Combination In Subjects With Locally Advanced or Metastatic Tumors
Active·2024·$0 / $635K·
External
oncology, clinical trial, cancer treatment, drug development, immunotherapy
A Phase 3 Randomized, Open-label Study Of Op-1250 Monotherapy Vs Standard Of Care For The Treatment Of Er+, Her2- Advanced Or Metastatic Breast Cancer Following Endocrine And Cdk 4/6 Inhibitor Therapy
Active·2024·$0 / $512.6K·
External
breast cancer, cancer treatment, monotherapy, endocrine therapy
A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer
Active·2024·$0 / $120.6K·
External
oncology, chemotherapy, hair loss, clinical trial

Page 1 of 3